LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Rheumatoid Arthritis patients study in a new report 'Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2017'.
Download the full report: https://www.reportbuyer.com/product/3895275The report provides insights into Rheumatoid Arthritis epidemiology, Rheumatoid Arthritis diagnosed patients, and Rheumatoid Arthritis treatment rate for top seven pharmaceutical
markets. The study measures key indicators such as prevalence of Rheumatoid Arthritis derived from epidemiological analysis, percentage of patients diagnosed with Rheumatoid Arthritis, and percentage of patients treated with a therapy. The study helps executives estimate Rheumatoid Arthritis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Rheumatoid Arthritis prevalence, Rheumatoid Arthritis diagnosis rate, and Rheumatoid Arthritis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources. Key Features of the Report: - Rheumatoid Arthritis Patient Flow - Rheumatoid Arthritis Prevalence - Rheumatoid Arthritis Diagnosed Patients - Rheumatoid Arthritis Treated PatientsDownload the full report: https://www.reportbuyer.com/product/3895275 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/global-rheumatoid-arthritis-epidemiology-and-patient-flow-analysis---2017-300558244.html